Serological and clinical surveillance studies to validate reported foot-and-mouth disease free status in Tsirang district of Bhutan

被引:4
|
作者
Dukpa, Kinzang [1 ,2 ]
Robertson, Ian D. [2 ]
Ellis, Trevor. M. [2 ]
机构
[1] Minist Agr & Forests, Dept Livestock, Natl Ctr Anim Hlth, Thimphu, Bhutan
[2] Murdoch Univ, Fac Hlth Sci, Sch Vet & Biomed Sci, Perth, WA, Australia
关键词
Foot-and-mouth disease; Surveillance; Non-structural proteins; Bhutan; LINKED IMMUNOSORBENT ASSAYS; NONSTRUCTURAL PROTEINS; DIFFERENTIATING INFECTION; VIRUS; ANTIBODIES; VACCINATION; CATTLE; 3ABC; SPECIFICITY; POPULATION;
D O I
10.1016/j.prevetmed.2011.10.015
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Serological and clinical studies were conducted between March 2009 and August 2010 to validate the foot-and-mouth disease free status of Tsirang district of Bhutan as determined by the country's passive surveillance system. Randomised (first survey) and targeted (third survey) samplings, with subsequent follow-up samplings (second and fourth), were conducted on FMD-susceptible animals to detect the disease at a design prevalence of 25% and 20% at the individual animal-level and village-level, respectively. Sera from cattle, goats, pigs, and sheep were tested for the presence of non-structural protein (NSP) antibodies using two commercial (PrioCHECK (R) FMDV NS and CHEKIT (R)-FMD-3ABC-bo-ov) and one in-house NSP kit (c-ELISA, AAHL, Australia). The overall seropositivity (all species) at the animal-level was 3% (95% Cl: 1.7, 4.8) and 3.5% (95% Cl: 2.1, 5.4), for the randomised and targeted surveys, respectively. Except for one goat from the first survey, none of the small ruminants and pigs had NSP antibodies. The seropositives from the first and targeted surveys were distributed among 13 and 16 of 20 villages sampled, respectively. All repeat testing from the initial seropositive animals and their herd mates, for both the first and third surveys, were negative in the NSP tests 6-8 months later. Using the hypergeometric exact probability formula for two-stage analyses, the results enabled rejection of the null hypothesis and supported conclusion that the population was free from disease at the minimum expected prevalence of 20% at the 95.53% and 99.46% confidence levels, for the randomised and targeted surveys, respectively. Clinical surveillance also showed absence of disease or clinical signs suggestive of FMD. The few seropositives were likely to be false positives due to factors such as imperfect specificities of the tests and possible NSP-residues in the vaccines. The study has paved the way for initiation of zoning approaches for the progressive control of FMD in Bhutan. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 11 条
  • [1] Evaluating serological tests for foot-and-mouth disease while accounting for different serotypes and uncertain vaccination status
    Jones, Geoff
    Heuer, Cord
    Johnson, Wes
    Begg, Douglas
    McFadden, Andrew
    Sutar, Ashish
    Abila, Ronello
    Browning, Clare
    Wilsden, Ginette
    Ludi, Anna B.
    Khounsy, Syseng
    Subharat, Supatsak
    PREVENTIVE VETERINARY MEDICINE, 2023, 214
  • [2] Vaccination against foot-and-mouth disease II: Regaining FMD-free status
    Backer, J. A.
    Engel, B.
    Dekker, A.
    van Roermund, H. J. W.
    PREVENTIVE VETERINARY MEDICINE, 2012, 107 (1-2) : 41 - 50
  • [3] Within herd transmission and evaluation of the performance of clinical and serological diagnosis of foot-and-mouth disease in partially immune cattle, herds
    Gonzales, J. L.
    Barrientos, M. A.
    Quiroga, L.
    Ardaya, D.
    Daza, O.
    Martinez, C.
    Orozco, C.
    Crowther, J.
    Paton, D. J.
    VACCINE, 2014, 32 (47) : 6193 - 6198
  • [4] The use of serosurveys following emergency vaccination, to recover the status of "foot-and-mouth disease free where vaccination is not practised"
    Paton, D. J.
    Fussel, A. -E.
    Vosloo, W.
    Dekker, A.
    De Clercq, K.
    VACCINE, 2014, 32 (52) : 7050 - 7056
  • [5] Comparing surveillance approaches to support regaining free status after a foot-and-mouth disease outbreak
    Garner, Graeme
    Vosloo, Wilna
    Tapsuwan, Sorada
    Bradhurst, Richard
    Seitzinger, Ann Hillberg
    Breed, Andrew C.
    Capon, Tim
    PREVENTIVE VETERINARY MEDICINE, 2021, 194
  • [6] Shifting to foot-and-mouth disease-free status without vaccination: Application of the PROMETHEE method to assist in the development of a foot-and-mouth national program in Uruguay
    Corbellini, Luis Gustavo
    Fernandez, Federico
    Vitale, Edgardo
    Olmos, Cyntia Moreira
    Charbonnier, Pablo
    Iriarte Barbosa, Maria Victoria
    Riet-Correa, Franklin
    PREVENTIVE VETERINARY MEDICINE, 2020, 181
  • [7] Investigation of the association between foot-and-mouth disease clinical signs and abattoir serological data in large ruminants in northern Lao People's Democratic Republic
    Gee, Emily
    Young, James R.
    Khounsy, Syseng
    Phommachanh, Phouvong
    Christensen, Peter
    Theppangna, Watthana
    Hughes, Tom
    Brownlie, Tom
    Temmerath, Adisone
    Inthavong, Alex
    Inthapanya, Phoummavanh
    Punyasith, Sivone
    Blacksell, Stuart D.
    Ward, Michael P.
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [8] The Impact of Resources for Clinical Surveillance on the Control of a Hypothetical Foot-and-Mouth Disease Epidemic in Denmark
    Halasa, Tariq
    Boklund, Anette
    PLOS ONE, 2014, 9 (07):
  • [9] Clinical and histopathological studies on neurodegeneration and dysautonomia in buffalo calves during foot-and-mouth disease outbreaks in Egypt
    Bayoumi, Yasmin
    Sobhy, Nader
    Morsi, Abdelkarem
    El-Neshwey, Wafaa
    El-Seddawy, Nora
    Abdallah, Abdelmonem
    VETERINARY WORLD, 2021, 14 (06) : 1622 - 1630
  • [10] A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance
    Barnett, P. V.
    Geale, D. W.
    Clarke, G.
    Davis, J.
    Kasari, T. R.
    TRANSBOUNDARY AND EMERGING DISEASES, 2015, 62 (04) : 367 - 387